Dominick Angiolillo, MD
Enriched profileDistinguished Professor of Medicine (with tenure); Chief, Division of Cardiology; Medical Director, UF Health Cardiovascular Center · University of Florida College of Medicine - Jacksonville
Dominick Angiolillo is Distinguished Professor of Medicine (with tenure); Chief, Division of Cardiology; Medical Director, UF Health Cardiovascular Center at University of Florida College of Medicine - Jacksonville. OpenAlex indexes 1,070 publications with 54,501 citations (h-index 111); ClinicalTrials.gov lists 34 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Dominick J. Angiolillo, MD, is Distinguished Professor of Medicine (with tenure) at University of Florida College of Medicine - Jacksonville, Department of Medicine, Division of Cardiology. The public record shows 1,070 publications with 54,501 citations (h-index 111), centered on Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics. It also documents an investigator role on 34 registered clinical trials, industry payments reported by 15 companies.
- Most recent indexed publication: 2026 · European heart journal. Acute cardiovascular care
- Top research focus: Antiplatelet Therapy and Cardiovascular Diseases
- 34 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 92 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 542.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 34 registered studies on ClinicalTrials.gov. The most recent:
- The Bridging Antiplatelet Therapy With Cangrelor 2 Study
Sponsor: University of Florida
- Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Sponsor: University of Florida
Industry payments
Updated 27 Aug 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year202510 payments$46,241openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20253 payments$18,335openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.4%Statin24.8%Atorvastatin Calcium82%Rosuvastatin Calcium13%Pravastatin Sodium5%Part D<11 patientsBeta blocker23.9%Carvedilol57%Metoprolol Succinate36%Metoprolol Tartrate7%Part D<11 patientsBlood & clotting
12.1%P2Y12 inhibitor8.3%Clopidogrel79%Brilinta21%Part D<11 patientsFactor Xa inhibitor3.8%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
1.5%Proton pump inhibitor1.5%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
1 congress contribution (2025) across ASH per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Managing bleeds on anticoagulant therapy: a practical guide for clinicians.
European heart journal. Acute cardiovascular care
Review2026 - Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI.
Clinical and translational science
Article2026 - Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies.
Nature reviews. Cardiology
Review2026 - Safety and Efficacy of Colchicine across the Spectrum of Coronary Artery Disease: A Systematic Review and Meta-Analysis of 20 Randomized Trials.
Clinical pharmacology and therapeutics
Meta-analysis2026 - Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial.
Journal of clinical medicine
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Ticagrelor with or without Aspirin in High-Risk Patients after PCI1,005 citations2019
- 04Variability in Individual Responsiveness to Clopidogrel959 citations2007
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dominick-angiolillo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
consultant360.com/podcast/cardiology/cardiometabolic-risk/dominick-angiolillo-md-phd-twilight-trial-analysis-high
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Ph.D. in Cellular and Molecular Cardiology
Catholic University of the Sacred Heart / Complutense University of Madrid
2006verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗
- Board Certified
Internal Medicine, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗ - Board Certified
Cardiovascular Disease, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.med.jax.ufl.edu ↗ - Board Certified
Interventional Cardiology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.med.jax.ufl.edu ↗
Editorial & leadership roles
journal and society appointments- Chief
Division of Cardiology, University of Florida College of Medicine - Jacksonville
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.med.jax.ufl.edu ↗ - Medical Director
UF Health Cardiovascular Center - Jacksonville
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.med.jax.ufl.edu ↗ - Director of Cardiovascular Research
UF College of Medicine - Jacksonville
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ufhealthjax.org ↗
Media & interviews
press, podcasts and appearances- TCT 2023 video
"Beyond the Data: The T-PASS Trial", post-PCI antiplatelet therapy discussion with Myeong-Ki Hong (TCTMD)
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology